Detail Information of Transcriptional Regulations
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0239 Transporter Info | ||||
Gene Name | SLC27A2 | ||||
Transporter Name | Very long-chain acyl-CoA synthetase | ||||
Gene ID | |||||
UniProt ID | |||||
Transcriptional Regulation of This DT (TSR) | ||||||
---|---|---|---|---|---|---|
Class1.1: Basic leucine zipper factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
CREB1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC27A2 gene | [1] | ||||
TF Protein Name |
Cyclic AMP-responsive element-binding protein 1 | Transcription Factor Info | ||||
Tissue |
Liver | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Cyclic AMP-responsive element-binding protein 1 (CREB1) can directly bind to the SLC27A2 gene, which in turn affects the expression or function of the drug transporter Very long-chain acyl-CoA synthetase. | |||||
Class1.2: Basic helix-loop-helix factors |
Click to Show/Hide the Full List of 4 TF(s) Regulating This DT |
|||||
AHR |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC27A2 gene in breast cancer condition | [2] | ||||
TF Protein Name |
Aryl hydrocarbon receptor | Transcription Factor Info | ||||
Affected Drug/Substrate |
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) | |||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Aryl hydrocarbon receptor (AHR) has been reported to activate the transcription of SLC27A2 gene in breast cancer condition, which leads to an increased expression of the drug transporter Very long-chain acyl-CoA synthetase. | |||||
ARNT |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC27A2 gene in breast cancer condition | [2] | ||||
TF Protein Name |
Aryl hydrocarbon receptor nuclear translocator | Transcription Factor Info | ||||
Affected Drug/Substrate |
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) | |||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Aryl hydrocarbon receptor nuclear translocator (ARNT) has been reported to activate the transcription of SLC27A2 gene in breast cancer condition, which leads to an increased expression of the drug transporter Very long-chain acyl-CoA synthetase. | |||||
MYC |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC27A2 gene in embryonic stem cells condition | [3] | ||||
TF Protein Name |
Myc proto-oncogene protein | Transcription Factor Info | ||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Myc proto-oncogene protein (MYC) has been reported to bind to the transcription of SLC27A2 gene in embryonic stem cells condition, which leads to an affected expression of the drug transporter Very long-chain acyl-CoA synthetase. | |||||
SREBF1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC27A2 gene in obesity condition | [4] | ||||
TF Protein Name |
Sterol regulatory element-binding protein 1 | Transcription Factor Info | ||||
Affected Drug/Substrate |
Triheptanoin | |||||
Studied Phenotype |
Obesity [ICD11: 5B81] | |||||
Tissue |
Liver | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
C57BL/6J mice | |||||
Detailed Description |
Sterol regulatory element-binding protein 1 (SREBF1) has been reported to activate the transcription of SLC27A2 gene in obesity condition, which leads to an increased expression of the drug transporter Very long-chain acyl-CoA synthetase. | |||||
Class1.3: Basic helix-span-helix factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
TFAP2C |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC27A2 gene in breast cancer condition | [5] | ||||
TF Protein Name |
Transcription factor AP-2 gamma | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Transcription factor AP-2 gamma (TFAP2C) has been reported to activate the transcription of SLC27A2 gene in breast cancer condition, which leads to an increased expression of the drug transporter Very long-chain acyl-CoA synthetase. | |||||
Class2.1: Nuclear receptors with C4 zinc fingers |
Click to Show/Hide the Full List of 4 TF(s) Regulating This DT |
|||||
HNF4A |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC27A2 gene in health condition | [6] | ||||
TF Protein Name |
Hepatocyte nuclear factor 4-alpha | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Hepatocyte nuclear factor 4-alpha (HNF4A) has been reported to bind to the transcription of SLC27A2 gene in health condition, which leads to an affected expression of the drug transporter Very long-chain acyl-CoA synthetase. | |||||
PPARA |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC27A2 gene in health condition | [7] | ||||
TF Protein Name |
Peroxisome proliferator-activated receptor alpha | Transcription Factor Info | ||||
Studied Phenotype |
Heallth [ICD11: N.A] | |||||
Tissue |
Intestine | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
C57BL/6 mice | |||||
Detailed Description |
Peroxisome proliferator-activated receptor alpha (PPARA) has been reported to activate the transcription of SLC27A2 gene in health condition, which leads to an increased expression of the drug transporter Very long-chain acyl-CoA synthetase. | |||||
RXRA |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Repression of SLC27A2 gene in pregnancy condition | [8] | ||||
TF Protein Name |
Retinoic acid receptor RXR-alpha | Transcription Factor Info | ||||
Affected Drug/Substrate |
Free fatty acids | |||||
Studied Phenotype |
Pregnancy [ICD11: JA00-JA2Z] | |||||
Tissue |
Placenta | |||||
Related DT Changes |
Down regulating | |||||
Experimental Material |
Human placenta cell isolates | |||||
Detailed Description |
Retinoic acid receptor RXR-alpha (RXRA) has been reported to repress the transcription of SLC27A2 gene in pregnancy condition, which leads to a decreased expression of the drug transporter Very long-chain acyl-CoA synthetase. | |||||
VDR |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC27A2 gene in leukemia condition | [9] | ||||
TF Protein Name |
Vitamin D3 receptor | Transcription Factor Info | ||||
Affected Drug/Substrate |
1,25(OH)2D3 | |||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Vitamin D3 receptor (VDR) has been reported to activate the transcription of SLC27A2 gene in leukemia condition, which leads to an increased expression of the drug transporter Very long-chain acyl-CoA synthetase. | |||||
Class2.3: C2H2 zinc finger factors |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
YY1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC27A2 gene in melanocyte deficiency condition | [10] | ||||
TF Protein Name |
Transcriptional repressor protein YY1 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Transcriptional repressor protein YY1 (YY1) has been reported to bind to the transcription of SLC27A2 gene in melanocyte deficiency condition, which leads to an affected expression of the drug transporter Very long-chain acyl-CoA synthetase. | |||||
ZNF217 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC27A2 gene in breast cancer condition | [11] | ||||
TF Protein Name |
Zinc finger protein 217 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Zinc finger protein 217 (ZNF217) has been reported to bind to the transcription of SLC27A2 gene in breast cancer condition, which leads to an affected expression of the drug transporter Very long-chain acyl-CoA synthetase. | |||||
Class3.3: Fork head / winged helix factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
E2F1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC27A2 gene in MCF7 cells | [12] | ||||
TF Protein Name |
Transcription factor E2F1 | Transcription Factor Info | ||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Transcription factor E2F1 (E2F1) has been reported to bind to the transcription of SLC27A2 gene in MCF7 cells, which leads to an affected expression of the drug transporter Very long-chain acyl-CoA synthetase. | |||||
Class6.3: p53 domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
TP63 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC27A2 gene in epithelial to mesenchymal transition condition | [13] | ||||
TF Protein Name |
Tumor protein 63 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Tumor protein 63 (TP63) has been reported to bind to the transcription of SLC27A2 gene in epithelial to mesenchymal transition condition, which leads to an affected expression of the drug transporter Very long-chain acyl-CoA synthetase. | |||||
Class6.5: T-Box factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
EOMES |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC27A2 gene in health condition | [14] | ||||
TF Protein Name |
Eomesodermin homolog | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Eomesodermin homolog (EOMES) has been reported to activate the transcription of SLC27A2 gene in health condition, which leads to an increased expression of the drug transporter Very long-chain acyl-CoA synthetase. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.